Non-steroidal anti-inflammatory drugs for lower urinary tract symptoms in benign prostatic hyperplasia: systematic review and meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Non-steroidal anti-inflammatory drugs for lower urinary tract symptoms in benign prostatic hyperplasia: systematic review and meta-analysis of randomized controlled trials

Published:2013-01-29 Issue:2 Volume:111 Page:304-311
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Kahokehr Arman¹,Vather Ryash²,Nixon Anthony¹,Hill Andrew G.³

Affiliation:

1. Department of Urology; Northland District Health Board; Whangarei Hospital; Whangarei

2. Department of Surgery; Faculty of Medicine and Health Sciences; University of Auckland; Auckland; New Zealand

3. Department of Surgery; South Auckland Clinical School; University of Auckland; Auckland; New Zealand

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2012.11559.x/fullpdf

Reference34 articles.

1. BPH: epidemiology and comorbidities;McVary;Am J Manag Care,2006

2. The natural history of benign prostatic hyperplasia;Fitzpatrick;BJU Int,2006

3. Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: a retrospective analysis;Di Silverio;Eur Urol,2003

4. Patterns of inflammation in prostatic hyperplasia: a histologic and bacteriologic study;Kohnen;J Urol,1979

5. Biomarkers of systemic inflammation and risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial;Schenk;Am J Epidemiol,2010

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benign prostatic hyperplasia nodules in patients treated with celecoxib and/or finasteride have reduced levels of NADH dehydrogenase [ubiquinone] iron‐sulfur protein 3, a mitochondrial protein essential for efficient function of the electron transport chain;The Prostate;2024-07-14

2. Development and validation of a clinical nomogram to predict prostatic inflammation in men with lower urinary tract symptoms;Prostate Cancer and Prostatic Diseases;2024-07-06

3. Emerging drugs for the treatment of benign prostatic hyperplasia: a 2023 update;Expert Opinion on Emerging Drugs;2024-06-14

4. Clinical value of neutrophil to lymphocyte ratio and ultrasonic parameters in the diagnosis of bladder outlet obstruction in benign prostatic hyperplasia;The French Journal of Urology;2024-06

5. Early investigational agents for the treatment of benign prostatic hyperplasia’;Expert Opinion on Investigational Drugs;2024-03-04